These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 26554666)
1. Understanding adverse drug reactions in package leaflets - an exploratory survey among health care professionals. Mühlbauer V; Mühlhauser I BMC Health Serv Res; 2015 Nov; 15():505. PubMed ID: 26554666 [TBL] [Abstract][Full Text] [Related]
2. Alternative package leaflets improve people's understanding of drug side effects-A randomized controlled exploratory survey. Mühlbauer V; Prinz R; Mühlhauser I; Wegwarth O PLoS One; 2018; 13(9):e0203800. PubMed ID: 30212555 [TBL] [Abstract][Full Text] [Related]
3. Comprehension of the description of side effects in drug information leaflets: a survey of doctors, pharmacists and lawyers. Ziegler A; Hadlak A; Mehlbeer S; König IR Dtsch Arztebl Int; 2013 Oct; 110(40):669-73. PubMed ID: 24167524 [TBL] [Abstract][Full Text] [Related]
4. Experiences relating to adverse drug reactions in the community: a cross-sectional survey among patients and the general public in Thailand. Patsuree A; Krska J; Jarernsiripornkul N Expert Opin Drug Saf; 2016; 15(3):287-95. PubMed ID: 26750422 [TBL] [Abstract][Full Text] [Related]
5. Trends in the receipt of medicines information among Finnish adults in 1999-2014: a nationwide repeated cross-sectional survey. Mononen N; Airaksinen MSA; Hämeen-Anttila K; Helakorpi S; Pohjanoksa-Mäntylä M BMJ Open; 2019 Jun; 9(6):e026377. PubMed ID: 31203239 [TBL] [Abstract][Full Text] [Related]
6. Validation of a new tool for evaluating subjects' satisfaction with medicine package leaflets: a cross-sectional descriptive study. Pires C; Rosa PJ; Vigário M; Cavaco A Sao Paulo Med J; 2019; 137(5):454-462. PubMed ID: 31939571 [TBL] [Abstract][Full Text] [Related]
7. [Quality improvement of health information included in drug information leaflets. Patient and health professional expectations]. March Cerdá JC; Prieto Rodríguez MA; Ruiz Azarola A; Simón Lorda P; Barrio Cantalejo I; Danet A Aten Primaria; 2010 Jan; 42(1):22-7. PubMed ID: 19632005 [TBL] [Abstract][Full Text] [Related]
8. Knowledge about Ultraviolet Radiation Hazards and Tanning Behavior of Cosmetology and Medical Students. Zuba EB; Francuzik W; Malicki P; Osmola-Mańkowska A; Jenerowicz D Acta Dermatovenerol Croat; 2016 Apr; 24(1):73-7. PubMed ID: 27149135 [TBL] [Abstract][Full Text] [Related]
9. People's Understanding of Verbal Risk Descriptors in Patient Information Leaflets: A Cross-Sectional National Survey of 18- to 65-Year-Olds in England. Webster RK; Weinman J; Rubin GJ Drug Saf; 2017 Aug; 40(8):743-754. PubMed ID: 28497250 [TBL] [Abstract][Full Text] [Related]
10. Readability of medicinal package leaflets: a systematic review. Pires C; Vigário M; Cavaco A Rev Saude Publica; 2015; 49():4. PubMed ID: 25741660 [TBL] [Abstract][Full Text] [Related]
11. Attitudes and experiences of community pharmacists towards paediatric off-label prescribing: a prospective survey. Stewart D; Rouf A; Snaith A; Elliott K; Helms PJ; McLay JS Br J Clin Pharmacol; 2007 Jul; 64(1):90-5. PubMed ID: 17324238 [TBL] [Abstract][Full Text] [Related]
12. The possible harms of statins: What do product labels, patient package inserts, and pharmacy leaflets tell us? Doshi P; Sieluk J; Hung A J Am Pharm Assoc (2003); 2019; 59(2):195-201. PubMed ID: 30661956 [TBL] [Abstract][Full Text] [Related]
13. Attitudes of physicians, pharmacists, and laypersons toward seriousness and need for disclosure of prescription drug side effects. Keown C; Slovic P; Lichtenstein S Health Psychol; 1984; 3(1):1-11. PubMed ID: 6536479 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys. Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758 [TBL] [Abstract][Full Text] [Related]
15. Package leaflets of the most consumed medicines in Portugal: safety and regulatory compliance issues. A descriptive study. Pires C; Vigário M; Cavaco A Sao Paulo Med J; 2015; 133(2):91-100. PubMed ID: 25337666 [TBL] [Abstract][Full Text] [Related]
16. Risk perception by healthcare professionals related to drug use during pregnancy: a Swiss survey. Csajka C; Jaquet A; Winterfeld U; Meyer Y; Einarson A; Panchaud A Swiss Med Wkly; 2014 Mar; 144():w13936. PubMed ID: 24610065 [TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacists' opportunities to reduce inappropriate prescription of QT-prolonging medications: calls to action. Dhanani TC; Mantovani EH; Turner JR Int J Pharm Pract; 2017 Apr; 25(2):176-179. PubMed ID: 27677250 [TBL] [Abstract][Full Text] [Related]
18. Readability Analysis of the Package Leaflets for Biological Medicines Available on the Internet Between 2007 and 2013: An Analytical Longitudinal Study. Piñero-López MÁ; Modamio P; Lastra CF; Mariño EL J Med Internet Res; 2016 May; 18(5):e100. PubMed ID: 27226241 [TBL] [Abstract][Full Text] [Related]
19. Survey of outpatients' use and needs of patient medicine information leaflets in Thailand. Pongpunna S; Pratipanawatr T; Jarernsiripornkul N Int J Clin Pharm; 2019 Feb; 41(1):141-150. PubMed ID: 30446897 [TBL] [Abstract][Full Text] [Related]
20. Perspective of Saudi undergraduate pharmacy students on pharmacovigilance and adverse drug reaction reporting: A National Survey. Alkayyal N; Cheema E; Hadi MA Curr Pharm Teach Learn; 2017 Sep; 9(5):779-785. PubMed ID: 29233304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]